Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.

Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...

Stock analysts at Leerink Partnrs lifted their Q4 2025 earnings per share (EPS) estimates for shares of Illumina in a ...

Elanco Animal Health Inc (ELAN) stock saw a modest uptick, ending the day at $12.08 which represents a slight increase of $0.02 or 0.17% from the prior close of $12.06. The stock opened at $12.1 and ...

Envista Holdings Corp (NVST) stock saw a modest uptick, ending the day at $21.45 which represents a slight increase of $0.15 or 0.70% from the prior close of $21.3. The stock opened at $21.29 and ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...

Fintel reports that on January 8, 2025, Leerink Partners downgraded their outlook for Accolade (NasdaqGS:ACCD) from Outperform to Market Perform. Analyst Price Forecast Suggests 6.67% Upside As of ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Quest Diagnostics (NYSE:DGX) from Market Perform to Outperform. Analyst Price Forecast Suggests 15.27% Upside As of ...